Elanco Animal Health (ELAN) Assets Average (2018 - 2026)
Elanco Animal Health (ELAN) reported Assets Average of $13.3 billion for Q1 2026, up 4.01% on a YoY basis from $12.8 billion in Q1 2025, and down 1.22% sequentially from $13.5 billion in Q4 2025.
Elanco Animal Health (ELAN) Assets Average (2018 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 9 years of Assets Average data on file, last reported at $13.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 4.01% year-over-year to $13.3 billion; the trailing twelve-month figure through Mar 2026 stood at $13.3 billion (up 4.01% YoY), and the FY2025 full-year result was $13.0 billion, down 3.72% from the prior year.
- Assets Average fell to $13.3 billion in Q1 2026, from $13.5 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $16.4 billion in Q1 2022 to a low of $12.8 billion in Q1 2025.
- A 5-year average of $14.4 billion and a median of $14.2 billion in 2024 frame the typical range for Assets Average.
- Across the five-year window, Assets Average fell 11.98% in 2024 and gained 4.01% in 2026, its largest moves.
- Tracing ELAN's Assets Average over 5 years: stood at $15.2 billion in 2022, then slipped by 5.69% to $14.4 billion in 2023, then slipped by 9.79% to $12.9 billion in 2024, then gained by 3.91% to $13.5 billion in 2025, then fell by 1.22% to $13.3 billion in 2026.
- Business Quant data shows ELAN's Assets Average at $13.3 billion in Q1 2026, $13.5 billion in Q4 2025, and $13.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 7.30 Bn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | 21.86 Mn |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 873.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.29 Bn |
| Dec 31, 2025 | 13.45 Bn |
| Sep 30, 2025 | 13.65 Bn |
| Jun 30, 2025 | 13.34 Bn |
| Mar 31, 2025 | 12.78 Bn |
| Dec 31, 2024 | 12.95 Bn |
| Sep 30, 2024 | 13.52 Bn |
| Jun 30, 2024 | 13.89 Bn |
| Mar 31, 2024 | 14.19 Bn |
| Dec 31, 2023 | 14.35 Bn |
| Sep 30, 2023 | 15.07 Bn |
| Jun 30, 2023 | 15.78 Bn |
| Mar 31, 2023 | 15.63 Bn |
| Dec 31, 2022 | 15.22 Bn |
| Sep 30, 2022 | 15.27 Bn |
| Jun 30, 2022 | 15.93 Bn |
| Mar 31, 2022 | 16.36 Bn |
| Dec 31, 2021 | 16.52 Bn |
| Sep 30, 2021 | 16.70 Bn |
| Jun 30, 2021 | 16.91 Bn |